T-cell-targeted therapies in rheumatoid arthritis (Q36577464)

15 August 2017

1 reference

title

T-cell-targeted therapies in rheumatoid arthritis (English)

1 reference

15 August 2017

1 reference

1

Cornelia M Weyand

1 reference

15 August 2017

Jörg J Goronzy

2

1 reference

15 August 2017

publication date

1 April 2006

1 reference

Nature Clinical Practice Rheumatology

15 August 2017

published in

1 reference

15 August 2017

volume

2

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

201-210

1 reference

The influence of age on T cell generation and TCR diversity

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

Ectopic lymphoid organogenesis: a fast track for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

T cell activation in rheumatoid synovium is B cell dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

Lymphoid neogenesis in rheumatoid synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

How should we manage early rheumatoid arthritis? From imaging to intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

1 reference

7 January 2021

Rheumatoid arthritis: non-tumor necrosis factor targets

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Understanding the generation and function of memory T cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

NFAT proteins: key regulators of T-cell development and function

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Development and function of T helper 1 cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

TNF/TNFR family members in costimulation of T cell responses

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

CD28-mediated co-stimulation: a quantitative support for TCR signalling

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

The double life of NK receptors: stimulation or co-stimulation?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Regulation of immune and autoimmune responses by ICOS-B7h interaction

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

The regulation of lymphocyte activation by inhibitory receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

B cells in rheumatoid synovitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

BLyS and APRIL in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

T-cell regulation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Ectopic Germinal Center Formation in Rheumatoid Synovitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Hypoxia and angiogenesis in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

An update on the cytokine network in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Abandoned therapies and unpublished trials in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

T cell homeostasis in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Recent developments in immunomodulatory peptides in juvenile rheumatic diseases: from trigger to dimmer?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

The evolving clinical profile of abatacept (CTLA4-Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Psoriasis vulgaris: an interplay of T lymphocytes, dendritic cells, and inflammatory cytokines in pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Cell-cell interactions in synovitis. Interactions between T cells and B cells in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Immunosenescence, autoimmunity, and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Modulation of CD28 expression with anti-tumor necrosis factor α therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0142

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0142

1 reference

release_nf2hn3doqjesxauu2gu5kzeuj4

15 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nf2hn3doqjesxauu2gu5kzeuj4

24 November 2022

mapped directly with Wikidata item

1 reference